Peter Elkin in a computing facility.
11/12/19

Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.

10/2/19

Peter L. Elkin, MD, professor and chair of biomedical informatics has been inducted as a fellow into the International Academy of Health Sciences Informatics (IAHSI).

9/17/19

Eighty-four student-scientists presented projects during the Ninth Annual Buffalo Summer Research Conference, an interdisciplinary forum marking the culmination of their summer research in Buffalo.

7/30/19

Department of Neurology researchers are helping to shed light on the effects of using gadodiamide as an imaging linear contrast agent in multiple sclerosis (MS) patients.

Upcoming Events

No events scheduled.